This study will be a longitudinal cohort study which will enroll, for the purposes of careful monitoring, an anticipated 250 adolescents (aged 13-20 years, inclusive) who are currently or prospectively identified in ACTG centers. Patients will have regularly scheduled office visits and have clinical and laboratory evaluations performed.
Showing the most recent 10 out of 869 publications